References of "Von Frenckell, Christian"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailTwo spondylodiscitis due to a contamination by Brucella melitensis in a mother and daughter back from holidays
MALAISE, Olivier ULg; LIBON, Florence ULg; BRICMAAN J et al

in Revue Médicale de la Suisse Romande (2014), 10(404), 197-200

Detailed reference viewed: 13 (1 ULg)
Full Text
Peer Reviewed
See detailThe management of systemic lupus erythematosus with biological therapies
MALAISE, Olivier ULg; VON FRENCKELL, Christian ULg; ANDRE, Béatrice ULg et al

in Revue Médicale Suisse (2013), 9(395), 1507-11

Detailed reference viewed: 16 (0 ULg)
Full Text
Peer Reviewed
See detailRhupus: when rheumatoid arthritis meets lupus
MALAISE, Olivier ULg; HALLEUX, Sandrine ULg; VON FRENCKELL, Christian ULg et al

in Revue Médicale de Liège (2012), 67(9), 475-84

Detailed reference viewed: 21 (4 ULg)
Full Text
Peer Reviewed
See detailGenetic and environmental interactions on the development of rheumatoid arthritis
MALAISE, Olivier ULg; VON FRENCKELL, Christian ULg; Malaise, Michel ULg

in Revue Médicale de Liège (2012), 67(5-6), 305-13

Detailed reference viewed: 11 (0 ULg)
Full Text
See detailTargeted therapy in inflammatory disease: cytokines
VON FRENCKELL, Christian ULg; Malaise, Michel ULg

in Revue Médicale de Liège (2012), 67(22-8),

Detailed reference viewed: 14 (0 ULg)
Full Text
Peer Reviewed
See detailLes traitements biologiques en rhumatologie
Von Frenckell, Christian ULg; Malaise, Michel ULg

in Revue Médicale de Liège (2009), 64(5-6), 293-300

Biological therapies consisting of monoclonal antibodies and soluble receptors have revolutionized the care of rheumatologic patients. These therapies ensued from a better understanding of the ... [more ▼]

Biological therapies consisting of monoclonal antibodies and soluble receptors have revolutionized the care of rheumatologic patients. These therapies ensued from a better understanding of the physiopathology of rheumatologic disorders. Most of the latter have been concerned: rheumatoid arthritis (for about 10 years), psoriatic arthritis and ankylosing spondilitys (for more or less five years). Rheumatology was among the first disciplines to make use of these advances; it continues to benefit from the results of intense research efforts. These developments request from clinicians an increased expertise in immunology. [less ▲]

Detailed reference viewed: 135 (9 ULg)
Full Text
Peer Reviewed
See detailLe traitement biologique des maladies inflammatoires à médiation immune. Le cas de la dermatologie et de la rhumatologie
Von Frenckell, Christian ULg; Henno, Audrey ULg; de LA BRASSINNE, Michel ULg et al

in Revue Médicale de Liège (2007), 62(Spec No), 55-62

The pathophysiology and the treatment of diseases with clinical presentation so different as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and psoriasis vulgaris have been ... [more ▼]

The pathophysiology and the treatment of diseases with clinical presentation so different as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and psoriasis vulgaris have been revolutionized by the discovery of common pro-inflammatory effector mechanisms involving TNF-alpha and by the use of targeted therapies, the anti-TNF-alpha antibodies. In the past 10 years, our experience has helped several hundreds of patients who were treated with novel drugs, years before they became routinely available. In parallel tools of metrology were developped that can now be applied to the routine patient. Lastly, clinical research on these new drugs has also generated derived research works allowing the university hospital to satisfactorilly fullfil its specific missions. [less ▲]

Detailed reference viewed: 238 (9 ULg)